Ş. B. TUNÇER Et Al. , "Aberrant miR-3135b and miR-1273g-3p expression in the peripheral blood samples of BRCA1/2 (±) ovarian cancer patients," Heliyon , vol.10, no.1, 2024
TUNÇER, Ş. B. Et Al. 2024. Aberrant miR-3135b and miR-1273g-3p expression in the peripheral blood samples of BRCA1/2 (±) ovarian cancer patients. Heliyon , vol.10, no.1 .
TUNÇER, Ş. B., Celik, B., KILIÇ ERCİYAS, S., ŞÜKRÜOĞLU ERDOĞAN, Ö., PASİN, Ö., Avsar, M., ... Kurt Gultaslar, B.(2024). Aberrant miR-3135b and miR-1273g-3p expression in the peripheral blood samples of BRCA1/2 (±) ovarian cancer patients. Heliyon , vol.10, no.1.
TUNÇER, Şeref Et Al. "Aberrant miR-3135b and miR-1273g-3p expression in the peripheral blood samples of BRCA1/2 (±) ovarian cancer patients," Heliyon , vol.10, no.1, 2024
TUNÇER, Şeref B. Et Al. "Aberrant miR-3135b and miR-1273g-3p expression in the peripheral blood samples of BRCA1/2 (±) ovarian cancer patients." Heliyon , vol.10, no.1, 2024
TUNÇER, Ş. B. Et Al. (2024) . "Aberrant miR-3135b and miR-1273g-3p expression in the peripheral blood samples of BRCA1/2 (±) ovarian cancer patients." Heliyon , vol.10, no.1.
@article{article, author={Şeref Buğra TUNÇER Et Al. }, title={Aberrant miR-3135b and miR-1273g-3p expression in the peripheral blood samples of BRCA1/2 (±) ovarian cancer patients}, journal={Heliyon}, year=2024}